Determination of 4,5-dihydro-6-[4-(1H-imidazol-1-yl) phenyl]-3(2H)-pyridazinone hydrochloride, a new cardiotonic, in plasma and urine by reversed-phase high-performance liquid chromatography.

A G Hayes, S Mehta, T Chang

Index: J. Chromatogr. A. 336(2) , 446-51, (1984)

Full Text: HTML

Abstract

Related Compounds

Related Articles:

New mechanisms for positive inotropic agents: focus on the discovery and development of imazodan.

1989-03-01

[Cardiovasc. Drugs Ther. 3(1) , 29-42, (1989)]

Effect of a new phosphodiesterase type III inhibitor as a coronary vasodilator and positive inotropic agent.

1987-08-01

[Cardiovasc. Res. 21(8) , 593-600, (1987)]

Inotropic and chronotropic profile of MCI-154: comparison with isoproterenol and imazodan in guinea pig cardiac preparations.

1990-07-01

[J. Cardiovasc. Pharmacol. 16(1) , 59-67, (1990)]

Effects of CI-914 in congestive heart failure due to coronary artery disease or idiopathic cardiomyopathy.

1986-09-15

[Am. J. Cardiol. 58(7) , 596-600, (1986)]

[Phosphodiesterase inhibition as a new positive-inotropic principle].

1986-12-19

[Dtsch. Med. Wochenschr. 111(51-52) , 1971-7, (1986)]

More Articles...